Almost a third of families of children with newly diagnosed acute lymphocytic leukemia had housing or food-related hardships or "catastrophic" income loss during standard chemotherapy, according to a study reported here. #ASH25
www.medpagetoday.com/meetingcover...

A hospital policy to increase the use of perioperative tranexamic acid reduced blood transfusions during major noncardiac surgeries with no apparent impact on clotting events, a cluster randomized trial from Canada found. #ASH25
www.medpagetoday.com/meetingcover...

Combining teclistamab (Tecvayli) with subcutaneous daratumumab-hyaluronidase (Darzalex Faspro) significantly improved progression-free survival and overall survival in patients with relapsed/refractory multiple myeloma, the MajesTEC-3 trial showed. #ASH25
www.medpagetoday.com/meetingcover...

Challenging medical dogma, the use of IV iron therapy for hospitalized patients with iron deficiency #anemia dealing with acute infections was associated with a reduced risk for death, a retrospective study spanning a quarter-century found. #ASH25
www.medpagetoday.com/meetingcover...

In a phase III trial with potential practice-changing implications, the non-covalent Bruton's tyrosine kinase inhibitor pirtobrutinib (Jaypirca) induced a higher response rate in chronic lymphocytic leukemia versus covalent ibrutinib (Imbruvica). #ASH25
www.medpagetoday.com/meetingcover...

For triple-class exposed relapsed or refractory multiple myeloma with EMD, a combination of talquetamab (Talvey) and teclistamab (Tecvayli) achieved high response rates in updated results from the phase II RedirecTT-1 trial. #ASH25 @szusmani.bsky.social
www.medpagetoday.com/meetingcover...

Azacitidine and venetoclax (Venclexta) significantly improved event-free survival in newly diagnosed fit adults with acute myeloid leukemia compared with conventional induction chemotherapy, a phase II randomized trial showed. #ASH25
www.medpagetoday.com/meetingcover...

Thank you to Barbara Raymond for recommending that I apply to the Public Voices Fellowship on Technology in the Public Interest, my Op Ed Project mentor, Teresa Puente, for her supportive guidance with the process, and to @gfriedman.bsky.socialn for creating a home for my op-ed @ @medpagetoday.com.🫀